chloroquine has been researched along with triclosan in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Karmodiya, K; Mishra, S; Ramya, TN; Surolia, A; Surolia, N | 1 |
Dunne, MW; Fidock, DA; Nkrumah, LJ; Sacchettini, JC; Sidhu, AB; Sun, Q | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M | 1 |
Belluti, F; Bisi, A; Bolognesi, ML; Brun, R; Cavalli, A; Colizzi, F; Gobbi, S; Kostrewa, D; Lauciello, L; Perozzo, R; Rampa, A; Recanatini, M; Scapozza, L | 1 |
Andricopulo, AD; Bwalya, AG; Carballeira, NM; Cordero-Maldonado, ML; Crawford, AD; Guido, RV; Itoe, MA; Kaiser, M; Mota, MM; Tasdemir, D | 1 |
Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M | 1 |
Amanzougaghene, N; Amrane, D; Arnold, CS; Azas, N; Azqueta, A; Botté, C; Hutter, S; Louis, B; Mazier, D; Primas, N; Sanz-Serrano, J; Tajeri, S; Vanelle, P; Verhaeghe, P | 1 |
8 other study(ies) available for chloroquine and triclosan
Article | Year |
---|---|
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
Topics: Acetone; Animals; Antimalarials; Azithromycin; Cerulenin; Chloramphenicol; Clindamycin; Erythrocytes; Fatty Acids; Gene Dosage; Humans; Organelles; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Tetracycline; Thioctic Acid; Triclosan | 2007 |
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
Topics: Amodiaquine; Animals; Antimalarials; Azithromycin; DNA, Protozoan; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Models, Structural; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2010 |
Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
Topics: Animals; Antimalarials; Cell Line; Coumarins; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Molecular Docking Simulation; Plasmodium falciparum; Protein Binding; Protein Conformation; Structure-Activity Relationship | 2013 |
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
Topics: Animals; Antimalarials; Cell Line, Tumor; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Malaria; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Zebrafish | 2014 |
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan | 2021 |
Antiplasmodial 2-thiophenoxy-3-trichloromethyl quinoxalines target the apicoplast of Plasmodium falciparum.
Topics: Apicoplasts; Humans; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship | 2021 |